A Study of Atezolizumab Versus Observation as Adjuvant Therapy in Participants With High-Risk Muscle-Invasive Urothelial Carcinoma (UC) After Surgical Resection
Cancer Bladder Cancer
For the latest version of this information please go to www.forpatients.roche.com